METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Clinical trials for METASTATIC TRIPLE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis study tested a combination of two drugs, veliparib and lapatinib, in 20 people with metastatic triple negative breast cancer that had already been treated. The goal was to see if the combination was safe and could shrink tumors. Participants received both drugs, not a placeb…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 26, 2026 08:01 UTC
-
Old arthritis drug shows promise against aggressive breast cancer
Disease control CompletedThis study tested a drug called leflunomide, usually used for arthritis, in 17 women with metastatic triple negative breast cancer. The goal was to see if it is safe and can help control the cancer. The drug is taken daily by mouth and works by blocking a protein that cancer cell…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Joseph Sparano • Aim: Disease control
Last updated May 22, 2026 13:51 UTC